Mammalian target of rapamycin (mTOR) is a serine-threonine kinase of the phosphoinositide 3-kinase-related kinase (PIKK) family which plays a central role in cell growth and it is commonly dysregulated in cancer [1-6]. The gene discussed is MTOR; the disease is cancer.